Impact of natural disasters and infectious diseases on operations and development
First written in FY2020. 1 of 3 entries say "Restated". Latest entry: FY2024.
Kinjiro moved to the "Worse" side of this theme in 2025, 5 years after the typical company in this theme (2020).
The whole theme swung hardest in 2020: 24 of 39 companies on the "Worse" side.
1 other company's latest entry also says "Reframed".
- FY2024ReframedAnnual report
「The group's business activities have not previously been affected by disasters such as earthquakes, fires, floods or tsunamis. However, if a large-scale natural disaster, strike, terrorist attack or other event occurs in these regions, or if an infectious disease such as a novel virus occurs or spreads on a scale far exceeding expectations, this may affect all business activities, including sales activities and product development.」
The wording has changed from the previous reference specifically naming COVID-19 to the more general expression "infectious diseases such as novel viruses." - FY2021RestatedAnnual report
「If a large-scale natural disaster, strike, terrorist attack or other event occurs in these regions, or if an infectious disease such as a novel influenza virus or novel coronavirus infection occurs or spreads on a scale far exceeding expectations, this may affect all business activities, including sales activities and product development.」
The company continues to identify as risks the impact of natural disasters, infectious diseases and other events on sales and development at its sites in Tokyo, Osaka, Nagoya and Vietnam. - FY2020First statedAnnual report
「If a large-scale natural disaster, strike, terrorist attack or other event occurs in these regions, or if an infectious disease such as a novel influenza virus or novel coronavirus infection occurs or spreads on a scale far exceeding expectations, this may affect all business activities, including sales activities and product development.」
The company identifies as general risks the impact of natural disasters, infectious diseases and other events on business activities at its sales offices in Tokyo, Osaka and Nagoya and its development centers in Nagoya and Vietnam.